Galantamine treatment in Alzheimer's disease: response and long-term outcome in a routine clinical setting.

Galantamine treatment in Alzheimer's disease: response and long-term outcome in a routine clinical setting.

Item
http://www.wikidata.org/entity/Q35327053
Galantamine slows down plaque formation and behavioral decline in the 5XFAD mouse model of Alzheimer's disease.Long-term effect of galantamine on cognitive function in patients with Alzheimer's disease versus a simulated disease trajectory: an observational study in the clinical setting.Effectiveness and Safety of MLC601 in the Treatment of Mild to Moderate Alzheimer's Disease: A Multicenter, Randomized Controlled Trial.Progression of mild Alzheimer's disease: knowledge and prediction models required for future treatment strategies.Prediction models for assessing long-term outcome in Alzheimer's disease: a review.Nature as a source of metabolites with cholinesterase-inhibitory activity: an approach to Alzheimer's disease treatment.Nasal Application of the Galantamine Pro-drug Memogain Slows Down Plaque Deposition and Ameliorates Behavior in 5X Familial Alzheimer's Disease Mice.Long-Term Efficacy of Galantamine in Alzheimer's Disease: The Okayama Galantamine Study (OGS).Early- versus late-onset Alzheimer's disease in clinical practice: cognitive and global outcomes over 3 years.Galantamine treatment in outpatients with mild Alzheimer's disease.First in human study with a prodrug of galantamine: Improved benefit-risk ratio?Efficacy and safety of galantamine treatment for patients with Alzheimer's disease: a meta-analysis of randomized controlled trials.
P2860

Galantamine treatment in Alzheimer's disease: response and long-term outcome in a routine clinical setting.

Item
http://www.wikidata.org/entity/Q35327053
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Galantamine treatment in Alzhe ...... in a routine clinical setting.
@ast
Galantamine treatment in Alzhe ...... in a routine clinical setting.
@en
type
label
Galantamine treatment in Alzhe ...... in a routine clinical setting.
@ast
Galantamine treatment in Alzhe ...... in a routine clinical setting.
@en
prefLabel
Galantamine treatment in Alzhe ...... in a routine clinical setting.
@ast
Galantamine treatment in Alzhe ...... in a routine clinical setting.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
Galantamine treatment in Alzhe ...... in a routine clinical setting.
@en
P2093
P2860
P304
P31
P356
P407
P478
P50
P577
P5875
P698
P921
P932